US FDA clears expanded use of Alcresta Therapeutics’ RELiZORB cartridge for paediatric patients 1 year of age and older: Waltham, Massachusetts Friday, January 17, 2025, 17:00 H ...
January is that time of year when we pause to examine our health habits, and Surgeon General Vivek Murthy issued an advisory with an important data point to consider: the strong link between alcohol ...
This manuscript describes the identification and characterization of 12 specific phosphomimetic mutations in the recombinant full-length human tau protein that trigger tau to form fibrils. This ...
Diabetes is a leading cause of global mortality and disability, and its economic burden is substantial. This Review focuses on type 2 diabetes, which makes up 90–95% of all diabetes cases. Type 2 ...
VIVUS will be discussing its significant 2024 momentum during the J.P. Morgan Healthcare Conference, with an emphasis on what we as a company aim to achieve during the coming months around our novel ...